Spirocyclic degronimers for target protein degradation

A technology targeting ligands and carbocycles, applied in the fields of resisting vector-borne diseases, medical preparations with inactive ingredients, and medical preparations containing active ingredients, etc.

Pending Publication Date: 2019-04-02
C4 THERAPEUTICS INC
View PDF373 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This study suggests that thalidomide-cereblon binding in vi

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0833] Representative example 1: 2,6-diazaspiro[3.5]nonane-5,7-dione

[0834]

[0835] 3-(3-Methoxy-3-oxopropyl)azetidine-1,3-dicarboxylic acid 1-(tert-butyl)3-methyl ester:

[0836]

[0837] Azetidine-1,3-dicarboxylic acid 1-(tert-butyl)3-methyl ester (1 equivalent) was dissolved in dry tetrahydrofuran and cooled to -78°C. Then a solution of lithium hexamethyldisilazide (1.0 M in tetrahydrofuran) (1.1 equivalents) was added dropwise and the solution was stirred for 1 hour. Then methyl 3-bromopropionate (1 equivalent) was added dropwise. The reaction was allowed to stir for 30 minutes and then gradually warmed to room temperature. When the reaction was judged to be complete based on TLC or LCMS analysis, it was quenched with saturated aqueous ammonium chloride solution and diluted with ethyl acetate. The organic layer was separated and the aqueous layer was extracted with ethyl acetate (3x). The combined organic layer was washed with brine and dried over sodium sulfate, and then c

Example Embodiment

[0860] Representative example 2: 2-((2-hydroxyethyl)sulfonyl)-2,6-diazaspiro[3.5]nonane-5,7-dione

[0861]

[0862] 1-(Vinylsulfonyl)azetidine-3-carboxylic acid methyl ester:

[0863]

[0864] The Boc protected azetidine is dissolved in dioxane. HCl (4N in dioxane) was added and the solution was stirred at room temperature for 12 hours. Then the solvent was evaporated under reduced pressure. Then azetidine (1 equivalent) was dissolved in DCM and cooled to -40°C. Add triethylamine (1.5 equivalents), then DMAP (0.1 equivalents). A solution of vinylsulfonyl chloride (1.2 equivalents) in DCM was slowly added dropwise. The mixture was stirred until the starting material was consumed as judged by TLC or LCMS analysis. The reaction was then warmed to room temperature and filtered through silica gel. The filtrate was concentrated under reduced pressure and the crude material was purified on silica gel.

[0865] 1-((2-((tert-butyldimethylsilyl)oxy)ethyl)sulfonyl)azetidine-3-carboxylic aci

Example Embodiment

[0876] Representative example 3: 2-(2-hydroxyethyl)-2-methyl-1-oxa-6-azaspiro[3.5]nonane-5,7-dione:

[0877]

[0878] To a solution of 4-butenoic acid (1 equivalent) in dichloromethane at 0°C was added trimethylamine (2 equivalents), isobutyl chloroformate (1.1 equivalents) and N,O-dimethylhydroxylamine (1.05 Equivalent), then trimethylamine (2 equivalents). The reaction was stirred overnight at room temperature. Then it was treated with saturated aqueous sodium bicarbonate solution. The organic layer was separated and the aqueous layer was extracted with dichloromethane (3x). The combined organic layer was washed with brine and dried over sodium sulfate, then concentrated. The crude material was purified on silica gel (Goncalves-Martin, M. et al., Synlett, 2009, 17, ). The Weinreb amide was then dissolved in dry tetrahydrofuran and cooled to 0°C. Then vinyl Grignard reagent (0.7M in THF, 1.2 equivalents) was added dropwise. After 1 hour, the reaction was quenched with satura

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This invention provides compounds that have spirocyclic E3 Ubiquitin Ligase targeting moieties (Degrons), which can be used as is or linked to a targeting ligand for a protein that has been selected for in vivo degradation, and methods of use and compositions thereof as well as methods for their preparation.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner C4 THERAPEUTICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products